Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion

ConditionPleural Effusion, Malignant

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAssiut University

About this trial

To evaluate the ability of cancer ratio and pleural fluid markers to discriminate between malignant and non malignant effusion

Eligibility criteria

Qualifiers

Patients (100 cases) with exudative pleural effusion who will be admitted to Department of Chest diseases and Tuberculosis, Assiut University Hospital

Disqualifiers

Age ˂ 18 years

Refusal to participate in the study

Trial design

Treatments tested in this trial

pleural markers

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov